Published in Rheumatology (Oxford) on June 01, 2009
The Influence of Extracorporeal Photopheresis on Skin Sclerosis | NCT04752397
Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol (2010) 1.64
Drug target prediction and repositioning using an integrated network-based approach. PLoS One (2013) 1.18
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthritis Res Ther (2013) 1.07
The cutaneous vascular system in chronic skin inflammation. J Investig Dermatol Symp Proc (2011) 1.06
Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study. Arthritis Rheum (2010) 1.03
Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Mol Cell Proteomics (2011) 0.98
Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction. PLoS One (2013) 0.90
Vasculopathy in scleroderma. Semin Immunopathol (2015) 0.90
The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope. Am J Med Sci (2014) 0.87
The Role of PPAR Gamma in Systemic Sclerosis. PPAR Res (2015) 0.86
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol. BMC Musculoskelet Disord (2012) 0.84
High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis. Arthritis Res Ther (2013) 0.84
Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol (2015) 0.84
Progranulin: A key player in autoimmune diseases. Cytokine (2016) 0.83
Registry evaluation of digital ulcers in systemic sclerosis. Int J Rheumatol (2010) 0.83
Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res Ther (2010) 0.81
Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy. Int J Rheumatol (2010) 0.81
Serum galectin-3 level in systemic sclerosis. Clin Rheumatol (2013) 0.80
Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis. J Immunol Res (2015) 0.80
Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis. BMC Complement Altern Med (2014) 0.80
A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis. PLoS One (2012) 0.80
Lack of CTGF*-945C/G Dimorphism in Thai Patients with Systemic Sclerosis. Open Rheumatol J (2011) 0.80
Risk factors for body composition abnormalities in systemic sclerosis. Clin Rheumatol (2013) 0.78
The burden and measurement of cardiovascular disease in SSc. Nat Rev Rheumatol (2010) 0.78
Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy. Rheumatol Int (2013) 0.78
Impaired skeletal muscle microcirculation in systemic sclerosis. Arthritis Res Ther (2012) 0.77
A critical view on cardiovascular risk in systemic sclerosis. Rheumatol Int (2016) 0.76
Egr-ly awaiting a "personalized medicine" approach to treat scleroderma. J Cell Commun Signal (2012) 0.76
Systemic Sclerosis and Multiple Cancers of the Female Genital Tract: Prolonged Survival following Current Treatment Strategies. Case Rep Rheumatol (2012) 0.75
Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis. Front Immunol (2017) 0.75
Involvement of collagen-binding heat shock protein 47 in scleroderma-associated fibrosis. Protein Cell (2015) 0.75
Successful treatment with bosentan of lower extremity ulcers in a scleroderma patient. Case Rep Med (2013) 0.75
Tc-99m diethylenetriamine pentaacetic acid (DTPA) renal function reserve estimation: is it a reliable predictive tool for assessment of preclinical renal involvement in scleroderma patients? Clin Rheumatol (2012) 0.75
Treatment of systemic sclerosis: potential role for stem cell transplantation. Stem Cells Cloning (2009) 0.75
Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis. J Clin Rheumatol Musculoskelet Med (2010) 0.75
Molecular targets for therapy in systemic sclerosis. Fibrogenesis Tissue Repair (2012) 0.75
Serum adropin level and ENHO gene expression in systemic sclerosis. Clin Rheumatol (2016) 0.75
Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis. Rheumatol Int (2013) 0.75
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci (1998) 2.60
Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) (2006) 2.44
Characterization of a membrane-associated receptor from bovine liver that binds phosphomannosyl residues of bovine testicular beta-galactosidase. Proc Natl Acad Sci U S A (1981) 2.32
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. Nat Med (2001) 2.14
Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol (1991) 2.08
Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci (2000) 1.92
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol (1995) 1.82
Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures. J Biol Chem (1979) 1.80
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med (2003) 1.71
Identification of mannose 6-phosphate in glycoproteins that inhibit the assimilation of beta-galactosidase by fibroblasts. Proc Natl Acad Sci U S A (1979) 1.71
Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. Proc Natl Acad Sci U S A (1993) 1.68
Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol (1981) 1.58
A second streptomycin resistance gene from Streptomyces griseus codes for streptomycin-3"-phosphotransferase. Relationships between antibiotic and protein kinases. Arch Microbiol (1988) 1.56
The role of glycosidically bound mannose in the assimilation of beta-galactosidase by generalized gangliosidosis fibroblasts. Biochem Biophys Res Commun (1976) 1.53
Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol (2000) 1.51
Increased deposition of fibulin-2 in solar elastosis and its colocalization with elastic fibres. Br J Dermatol (2001) 1.51
Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma. Arch Dermatol (1997) 1.49
Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" phenotype. J Biol Chem (2001) 1.49
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc Natl Acad Sci U S A (1997) 1.47
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer (2002) 1.45
Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol (2000) 1.43
Enzymic synthesis of a diamino sugar nucleotide by extracts of type XIV Diplococcus pneumoniae. Arch Biochem Biophys (1966) 1.40
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis. Arthritis Rheum (2001) 1.39
Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest (1990) 1.36
Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest (1988) 1.35
Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res (1998) 1.33
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis (2005) 1.32
Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum (2004) 1.29
Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med (Berl) (1998) 1.28
Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet (1997) 1.25
Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp Cell Res (1988) 1.24
Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Ann Rheum Dis (2008) 1.22
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
The regulator of streptomycin gene expression, StrR, of Streptomyces griseus is a DNA binding activator protein with multiple recognition sites. Mol Microbiol (1995) 1.21
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol (2000) 1.19
Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem (1991) 1.19
Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J Biol Chem (1993) 1.18
UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res (1991) 1.17
The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol (2000) 1.17
Type III procollagen is the major collageneous component produced by a continuous rhabdomyosarcoma cell line. FEBS Lett (1979) 1.16
Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum (1990) 1.14
Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem (1999) 1.13
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis (2008) 1.13
Localization of collagen alpha 1(I) gene expression during wound healing by in situ hybridization. J Invest Dermatol (1989) 1.12
Extracellular matrix components synthesized by human amniotic epithelial cells in culture. Cell (1980) 1.12
The AcbC protein from Actinoplanes species is a C7-cyclitol synthase related to 3-dehydroquinate synthases and is involved in the biosynthesis of the alpha-glucosidase inhibitor acarbose. J Biol Chem (1999) 1.11
Disorder of collagen metabolism in a patient with osteogenesis imperfecta (lethal type): increased degree of hydroxylation of lysine in collagen types I and III. Eur J Clin Invest (1981) 1.11
Imatinib as a novel therapeutic approach for fibrotic disorders. Rheumatology (Oxford) (2008) 1.10
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis (2009) 1.09
Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J Invest Dermatol (1998) 1.09
Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis. Br J Dermatol (2011) 1.07
UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol (1994) 1.07
Mechanisms of vascular damage in SSc--implications for vascular treatment strategies. Rheumatology (Oxford) (2008) 1.07
Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol (2000) 1.06
Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts. J Invest Dermatol (1985) 1.06
Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol (1999) 1.05
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05
Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity. Rheumatology (Oxford) (2008) 1.03
A specific, sensitive method for the determination of hyaluronate. Anal Biochem (1979) 1.03
Downregulation of collagen synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and posttranscriptional mechanisms. FEBS Lett (1993) 1.03
Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma? Matrix Biol (2005) 1.03
Gene cluster for streptomycin biosynthesis in Streptomyces griseus: analysis of a central region including the major resistance gene. Mol Gen Genet (1987) 1.02
The marfan's syndrome. In vitro study of collagen metabolism in tissue specimens of the aorta. Exp Cell Biol (1977) 1.02
Osteogenesis imperfecta: biochemical and clinical evaluation of 13 cases. Klin Wochenschr (1981) 1.02
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol (2009) 1.01
Aminoterminal extension peptides from type I procollagen normalize excessive collagen synthesis of scleroderma fibroblasts. Arch Dermatol Res (1978) 1.01
Immunofluorescent localization of type IV collagen and laminin in human skin and its application in junctional zone pathology. Br J Dermatol (1982) 1.01
Caffeine hypersensitivity. Allergy (2002) 1.01
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology (Oxford) (2009) 1.01
Letters: Fibroblasts from a patient with scleroderma reveal abnormal metabolism. Arch Dermatol Res (1977) 1.01
Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol (1991) 1.00
Synthesis of collagen by human fibroblasts and their SV40 transformants. Exp Cell Res (1980) 1.00
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett (1989) 1.00
Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma. J Invest Dermatol (1986) 1.00
Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis. Ann Rheum Dis (2004) 0.99
Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma. J Dermatol Sci (1999) 0.99
Down-regulation of alpha 3(VI) chain expression by gamma-interferon decreases synthesis and deposition of collagen type VI. Eur J Biochem (1989) 0.99
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum (2011) 0.98
Influence of corticosteroids on chemotactic response and collagen metabolism of human skin fibroblasts. Biochem Pharmacol (1988) 0.98
Inhibition of fibroblast chemotaxis by superoxide dismutase. Eur J Cell Biol (1987) 0.98
Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol (2005) 0.98
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum (2009) 0.98
Regulation of collagen VI expression in fibroblasts. Effects of cell density, cell-matrix interactions, and chemical transformation. J Biol Chem (1989) 0.97
Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J (1996) 0.97
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum (2011) 0.96
Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun (2001) 0.96
Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis. J Dermatol Sci (2001) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96